June Visits 1 - 2: Severe Hypertriglyceridemia in a 6 Month Old Child

Lipemic Specimen
Launch Date:
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

​Don P. Wilson, MD, FNLA

Don P. Wilson, MD, FNLA 
Department of Pediatric Endocrinology and Diabetes
Cook Children's Medical Center, Fort Worth, Texas

A native of Newton, Mississippi, Dr. Don P. Wilson attended the University of Southern Mississippi, receiving a degree in pre-medical education.  He earned a medical degree from the University of Mississippi before completing Pediatric residency training and post-graduate fellowship in Pediatric Endocrinology at Baylor College of Medicine in Houston, Texas.  He is board certified in Pediatrics, Pediatric Endocrinology and Clinical Lipidology.
In 1997, Dr. Wilson was selected as Chairman of the Department of Pediatrics, Texas A&M University College of Medicine, a position he held for 12 years.  In addition to overseeing an active research and medical education program, Dr. Wilson was instrumental in creating one of the first cardiovascular risk assessment clinics for children and adolescents. This clinic provided education to encourage healthy lifestyles, developed effective screening strategies and created novel interventions to improve the health and well being of children and adolescents risk for premature cardiovascular disease and type 2 diabetes mellitus.
Although most of his professional focus has been in the area of childhood diabetes Dr. Wilson has expanded his role in the related areas of childhood obesity, insulin resistance and dyslipidemia. He is board certified by the American Board of Lipidology, a Fellow of the National Lipid Association and an Associate Editor for the Journal of Clinical Lipidology. Dr. Wilson is currently a member the Board of Directors of the Southwest Lipid Association and the American Board of Clinical Lipidology
Recognizing that current approaches have proven inadequate to identify and effectively address the growing concern of premature cardiovascular disease, Dr. Wilson has been working with local, regional and national experts create a better clinical care model that will provide enhanced health care, assessment, research and education for children and adolescents with genetic and acquired forms of dyslipidemia. 
In 2009 Dr. Wilson was recruited to Phoenix Children’s Hospital. Working with a host of primary care providers, community leaders and the academic community, Dr. Wilson was able to create a unique Cardiovascular Risk Assessment, Research and Education program (C.A.R.E.) serving as the program’s Director from 2009 – 2011. While in Arizona he severed as a member of Arizona’s AAP subcommittee for childhood obesity and was selected by the National American Academy of Pediatrics to serve on a task force to evaluate the feasibility of a national obesity registry. In 2011, Dr. Wilson was recruited to Cook Children’s Medical Center in Fort Worth where he currently serves as the Endowed Chair, Cardiovascular Health and Risk Prevention.

Catherine McNeal, MD, PhD, FNLA

Catherine McNeal, MD, PhD, FNLA
Department of Pediatrics, Scott and White Healthcare 
Texas A&M University, Temple, Texas

Dr. McNeal is a pediatrician and internist specializing in lipid disorders in adults and children at the Division of Cardiology at Baylor Scott & White Health. Her research focus involves screening and treatment of cardiovascular risk factors in youth and in the characterization of lipid subclasses using novel bioanalytical methods.

Piers Blackett, MB, ChB, FNLA

Piers Blackett, MB, ChB, FNLA
Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics
University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

Piers R Blackett, MB, ChB, FAAP, FNLA, a graduate of the University of Cape Town, South Africa, is a Professor of Pediatrics at the University of Oklahoma Health Sciences Center and practices pediatric endocrinology and lipidology at the OU Children's Hospital in Oklahoma City. He currently serves on the executive committee for the Pediatric Association of Lipidology and the South-West Lipid Association board. 
1. Discuss the pathophysiology associated with severe hypertriglyceridemia when present in young children 
2. Recognize the typical clinical presentation, including common symptoms and physical examination findings 
3. Generate an appropriate differential diagnosis 
4. Choose laboratory, imaging, and diagnostic studies, tests, and procedures helpful in confirming the diagnosis 
5. Recommend appropriate consultations, diets, and activities 
6. Demonstrate familiarity with choice of appropriate medications 
7. Discuss potential complications and prognosis